首页> 美国卫生研究院文献>Journal of Visualized Experiments : JoVE >A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
【2h】

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

机译:电化学发光免疫分析法测定血清心肌肌球蛋白结合蛋白-C的灵敏和定量方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Biomarkers are becoming increasingly more important in clinical decision-making, as well as basic science. Diagnosing myocardial infarction (MI) is largely driven by detecting cardiac-specific proteins in patients' serum or plasma as an indicator of myocardial injury. Having recently shown that cardiac myosin binding protein-C (cMyBP-C) is detectable in the serum after MI, we have proposed it as a potential biomarker for MI. Biomarkers are typically detected by traditional sandwich enzyme-linked immunosorbent assays. However, this technique requires a large sample volume, has a small dynamic range, and can measure only one protein at a time.Here we show a multiplex immunoassay in which three cardiac proteins can be measured simultaneously with high sensitivity. Measuring cMyBP-C in uniplex or together with creatine kinase MB and cardiac troponin I showed comparable sensitivity. This technique uses the Meso Scale Discovery (MSD) method of multiplexing in a 96-well plate combined with electrochemiluminescence for detection. While only small sample volumes are required, high sensitivity and a large dynamic range are achieved. Using this technique, we measured cMyBP-C, creatine kinase MB, and cardiac troponin I levels in serum samples from 16 subjects with MI and compared the results with 16 control subjects. We were able to detect all three markers in these samples and found all three biomarkers to be increased after MI. This technique is, therefore, suitable for the sensitive detection of cardiac biomarkers in serum samples.
机译:生物标志物在临床决策以及基础科学中变得越来越重要。诊断心肌梗塞(MI)在很大程度上是通过检测患者血清或血浆中的心脏特异性蛋白来指示心肌损伤的。最近显示出心肌梗死后血清中可检测到心肌肌球蛋白结合蛋白-C(cMyBP-C),我们提出将其作为心肌梗死的潜在生物标记。通常通过传统的夹心酶联免疫吸附测定法检测生物标志物。但是,这种技术需要大量的样品,动态范围小,一次只能测量一种蛋白质。在这里,我们展示了一种多重免疫测定法,其中可以同时高灵敏度地测定三种心脏蛋白质。单重或与肌酸激酶MB和心肌肌钙蛋白I一起测量cMyBP-C表现出相当的敏感性。这项技术使用在96孔板中与化学发光结合进行检测的介观尺度发现(MSD)方法进行检测。尽管只需要少量样品,但可以实现高灵敏度和大动态范围。使用此技术,我们测量了16名患有MI的受试者的血清样品中的cMyBP-C,肌酸激酶MB和心肌肌钙蛋白I水平,并将结果与​​16名对照受试者进行了比较。我们能够检测出这些样品中的所有三个标记,并发现MI后所有三个生物标记均增加。因此,该技术适用于灵敏检测血清样品中的心脏生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号